MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 29, 2008; DOI: 10.1124/mol.108.048819


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.108.048819v1
74/4/1163    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Green, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Green, T.


Received for publication May 16, 2008.
Revised June 26, 2008.
Accepted for publication July 28, 2008.

Mutations to the kainate receptor subunit GluR6 binding pocket that selectively affect domoate binding

Yihong Zhang 1, Naushaba Nayeem 1, Tim Green 1*

1 University of Liverpool

* Address correspondence to: E-mail: tpgreen{at}liv.ac.uk

Abstract

Kainate receptor responses to domoate are characterized by large steady-state currents and slow deactivation kinetics. To improve our understanding of these responses we mutated residues at the mouth of the agonist binding pocket of GluR6, using whole-cell electrophysiology to characterize the effects of the mutants. We identified two residues where mutations had significant ligand-specific effects. One, M691, forms a hydrogen bond that appears to facilitate domoate binding by affecting the main-chain conformation. We found that mutation of M691 to alanine significantly attenuated responses to domoate, while having no effect on responses to glutamate, confirming the importance of this main-chain interaction in GluR6. The second residue, V685, is located at the mouth of the binding pocket, adjacent to the domoate side-arm. Mutation of V685 to glutamine increased the rate of decay from steady-state responses to domoate by over 50-fold, while having no effect on the rate or extent of desensitization, or on the kinetics of responses to either glutamate or kainate. The V685Q mutant also significantly reduced the potencies of both glutamate (peak) and domoate (peak and steady-state). Empirical analysis using a basic kinetic model indicated that the V685Q phenotype could be fully explained by faster ligand dissociation. The V685Q mutant accelerated receptor deactivation without affecting either desensitization or gating, making it a potentially useful tool for further dissection of ligand binding and gating in kainate receptors.


Key words: Glutamate, Func. analysis receptor/ion channel mutants





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics